1. Cisplatin-Resistant Neuroblastoma Cells Express Enhanced Levels of Epidermal Growth Factor Receptor (EGFR) and Are Sensitive to Treatment with EGFR-Specific Toxins
   Martin Michaelis et al, 2008, Clinical Cancer Research CrossRef
2. Reversal of P-glycoprotein–Mediated Multidrug Resistance by the Murine Double Minute 2 Antagonist Nutlin-3
   Martin Michaelis et al, 2009, Cancer Research CrossRef
3. Incorporation of doxorubicin in different polymer nanoparticles and their anticancer activity
   Sebastian Pieper et al, 2019, Beilstein Journal of Nanotechnology CrossRef
4. p53 Determines Multidrug Sensitivity of Childhood Neuroblastoma
   Chengyuan Xue et al, 2007, Cancer Research CrossRef
5. Doxorubicin-loaded human serum albumin nanoparticles overcome transporter-mediated drug resistance in drug-adapted cancer cells
   Hannah Onafuye et al, 2019, Beilstein Journal of Nanotechnology CrossRef